Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: Secondary data analysis of a national survey

BMJ Open

Volumn 4, Issue 5, 2014, Pages

  Pérez Cuevas, Ricardo ^a   Doubova, Svetlana V ^b   Wirtz, Veronika J ^c,d   Servan Mori, Edson ^d   Dreser, Anahí ^d   Hernández Ávila, Mauricio ^d  

^a Inter American Development Bank   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONSULTATION; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH SERVICE; HOSPITAL; HUMAN; INTERVIEW; MALE; MEXICO; PHARMACY; PHYSICIAN; SOCIAL SECURITY; TRAFFIC AND TRANSPORT; HEALTH CARE FACILITY; INFANT; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; QUESTIONNAIRE; SOCIOECONOMICS; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; HEALTH EXPENDITURES; HUMANS; INFANT; MEXICO; MIDDLE AGED; PHARMACIES; PHYSICIANS' OFFICES; PRIVATE SECTOR; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84901393170     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004669     Document Type: Article

References (31)

1. Organisation for Economic Co-operation and Development. OECD Health Data 2013: how does Mexico compare. Organisation for Economic Co-operation and Development, 2013. http://www.oecd.org/mexico/Briefing-Note-MEXICO-2013.pdf
2. Organisation for Economic Co-operation and Development. An overview of growing income inequalities in OECD countries: main findings. Organisation for Economic Co-operation and Development, 2011. http://www.oecd.org/els/soc/ 49499779.pdf
3. Wirtz VJ, Reich MR, Leyva-Flores R, et al. Medicines in Mexico, 1990-2004: systematic review of research on access and use. Salud Publica Mex 2008;50:S470-9.
4. Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 2012;380:1259-79.
5. Fundación Mexicana para la Salud: Trabajando por la salud de la población. Propuestas de política para el sector farmacéutico. Versión para el diálogo. FUNSALUD, A. C., 2011. http://www.funsalud.org.mx/eventos-2011/trabajando%20por%20la%20salud/ Doc%20PolPublSFarm%20vFDigital%20060511.pdf
6. Dreser A, Vázquez-Vélez E, Treviño S, et al. Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health 2012;12:1051. http://www.biomedcentral.com/1471-2458/12/1051 (accessed 6 Mar 2013).
7. Federal Commission for Protection against Sanitary Risks (COFEPRIS). Strategies to regulate doctor's offices adjacent to private pharmacies. http://www.cofepris.gob.mx/Paginas/Inicio.aspx (accessed 30 Mar 2014).
8. Rodwin M, Okamoto A. Physicians' conflicts of interest in Japan and the United States: lessons for the United States. J Health Polit Policy Law 2000;25:343-75. (Pubitemid 30228505)
9. Kwon S. Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing. Soc Sci Med 2003;57:529-38. (Pubitemid 36677511)
10. Liu X, Mills A. The influence of bonus payments to doctors on hospital revenue: results of a quasi-experimental study. Appl Health Econ Health Policy 2003;2:91-8.
11. Sun Q, Santoro MA, Meng Q, et al. Pharmaceutical policy in China. Health Aff (Millwood) 2008;27:1042-50.
12. Trap B, Hansen EH, Hogerzeil H. Prescription habits of dispensing and non-dispensing doctors in Zimbabwe. Health Policy Plan 2002;17:288-95. (Pubitemid 34988079)
13. Park S, Soumerai SB, Adams AS, et al. Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy Plan 2005;20:302-9. (Pubitemid 41219872)
14. Chou YJ, Yip WC, Lee CH, et al. Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan's experience. Health Policy Plan 2003;18:316-29. (Pubitemid 37087221)
15. Romero-Martínez M, Shamah-Levy T, Franco-Núñez A, et al. National Health and Nutrition Survey 2012: design and coverage. Salud Publica Mex 2013;55:S332-40.
16. Brown C, Pagán J, Rodríguez-Oreggia E. The decision-making process of health-care utilization in Mexico. Health Policy 2005;72:81-91. (Pubitemid 40349010)
17. López-Ceballos D, Chi C. Health-care utilization in Ecuador: a multilevel analysis of socio-economic determinants and inequality issues. Health Policy Plan 2010;25:209-18.
18. Valdivia M. Public health infrastructure and equity in the utilization of outpatient health-care services in Peru. Health Policy Plan 2002;17:12-19. (Pubitemid 36041834)
19. Comisión Nacional para el Desarrollo de los Pueblos Indígenas (CDI). Los hogares y la población indígena. 2009. http://www.cdi.gob.mx/index.php?id=211&option=com-content&task=view (accessed 6 Mar 2013).
20. Consejo Nacional de Población (CONAPO). Índice de marginación por localidad. http:/www.conapo.gob.mx/es/CONAPO (accessed 20 Mar 2013).
21. Kolenikov S, Angeles G. The use of discrete data in PCA: theory, simulations, and applications to socioeconomic indices. Chapel Hill: Carolina Population Center, University of North Carolina, 2004.
22. McKenzie DJ. Measuring inequality with asset indicators. J Popul Econ 2005;2. http://siteresources.worldbank.org/DEC/Resources/finaljpopmckenzie1.pdf (accessed 2 Feb 2013).
23. Hosmer D, Lemeshow S. Applied logistic regression. 2nd edn. Wiley Series in Probability and Statistics, 2000.
24. Ministry of Health. Health Sector Program 2013-2018. Diario Oficial de la Federación 12.12.2013. México, 2013.
25. Muñoz O, Rodríguez-Ortega E, Pérez-Cuevas R, et al. Propuesta de un Sistema Nacional de Servicios de Salud: componente de salud de una propuesta de seguridad social universal. Documento elaborado por el Centro de Estudios Económicos y Sociales en Salud (CEESES) del Hospital Infantil de México Federico Gómez (HIMFG) para el Consejo Nacional de Evaluación de la Política de Desarrollo Social (CONEVAL). México: UNAM, Seminario sobre Medicina y Salud, 2012.
26. Farmacopea de los Estados Unidos Mexicanos. Suplemento para establecimientos dedicados a la venta y suministro de medicamentos y otros insumos para la salud. México: Secretaria de Salud, 2010.
27. Brody H. Professional medical organizations and commercial conflicts of interest: ethical issues. Ann Fam Med 2010;8:354-8.
28. Leyva-Piña MA, Pichardo-Palacios S. Los médicos de las Farmacias Similares: Degradación de la profesión médica? Polis 2012;8:143-75.
29. Iizuka T. Experts' agency problems: evidence from the prescription drug market in Japan. Rand J Econ 2007;38:844-62.
30. Spurling GK, Mansfield PR, Montgomery BD, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med 2010;7:e1000352. http://www. plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000352 (accessed 15 Jan 2013).
31. Watts JJ, Segal L. Market failure, policy failure and other distortions in chronic disease markets. BMC Health Serv Res 2009;9:102.